Congleton Jon's Form 4 filing
Mineralys Therapeutics, Inc. (MLYS) · filed Apr 2, 2026
- Accession no.
- 0001644975-26-000004
- Filed
- Apr 2, 2026
- Trade date
- Mar 31, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.97M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Congleton JonCIK 0001644975 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | SSaleDisposed | −19,364 | $25.50 | −$493,782 | 760,687 | Direct | |
| Mar 31, 2026 | Common Stock | SSaleDisposed | −55,183 | $26.54 | −$1,464,556.82 | 705,504 | Direct | |
| Mar 31, 2026 | Common Stock | SSaleDisposed | −453 | $27.05 | −$12,253.65 | 705,051 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.